|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.13 CNY | +1.82% |
|
-1.45% | -10.89% |
| May. 07 | Sheng Nuo Biotec's Unit Gets Nod to Produce Posaconazole Injection | MT |
| Apr. 22 | ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ChengDu ShengNuo Biotec Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 173.83 million compared to CNY 167.51 million a year ago. Net income was CNY 20.15 million compared to CNY 18.64 million a year ago.
Basic earnings per share from continuing operations was CNY 0.18 compared to CNY 0.17 a year ago. Diluted earnings per share from continuing operations was CNY 0.18 compared to CNY 0.17 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.89% | 389M | |
| +15.91% | 41.97B | |
| +22.40% | 22.34B | |
| +18.48% | 15.25B | |
| +16.12% | 14B | |
| +45.12% | 12.06B | |
| -9.58% | 6.8B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +14.18% | 5.49B |
CHENGDU SHENGNUO BIOTEC CO.,LTD. 
